Familial Hypertrophic Cardiomyopathy
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Familial Hypertrophic Cardiomyopathy

View Main Condition: Cardiomyopathy

What is the definition of Familial Hypertrophic Cardiomyopathy?

Hypertrophic cardiomyopathy is a heart condition that is characterized by the thickening (hypertrophy) of the heart (cardiac) muscle. This condition is called nonsyndromic hypertrophic cardiomyopathy when it is not associated with signs and symptoms affecting other parts of the body and when it cannot be explained by other causes, such as chronic high blood pressure.

What are the causes of Familial Hypertrophic Cardiomyopathy?

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in one of several genes can cause nonsyndromic hypertrophic cardiomyopathy, but variants in the MYH7 and MYBPC3 genes are the most common genetic cause of this condition.

How prevalent is Familial Hypertrophic Cardiomyopathy?

Hypertrophic cardiomyopathy affects approximately 1 in 500 people worldwide. Nonsyndromic hypertrophic cardiomyopathy likely accounts for more than half of all cases.

Is Familial Hypertrophic Cardiomyopathy an inherited disorder?

Nonsyndromic hypertrophic cardiomyopathy has different inheritance patterns depending on the specific gene involved. When nonsyndromic hypertrophic cardiomyopathy occurs in multiple family members, it may be called familial hypertrophic cardiomyopathy.

Who are the top Familial Hypertrophic Cardiomyopathy Local Doctors?
Elite in Familial Hypertrophic Cardiomyopathy
Elite in Familial Hypertrophic Cardiomyopathy
Referral may be required

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients

Sharlene Day is a Cardiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Day is rated as an Elite provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Orchiectomy. Dr. Day is board certified in Cardiovascular Disease, 2012. Dr. Day is currently accepting new patients.

Elite in Familial Hypertrophic Cardiomyopathy
Elite in Familial Hypertrophic Cardiomyopathy
Referral may be required
Barts Heart Centre St Bartholomew's Hospital, 
London, ENG, GB 

Perry Elliott practices practicing medicine in London, United Kingdom. Mr. Elliott is rated as an Elite expert by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Familial Hypertrophic Cardiomyopathy
Elite in Familial Hypertrophic Cardiomyopathy
Referral may be required

Brigham And Women's Hospital, Heart And Vascular Center

70 Francis Street, Carl J. And Ruth Shapiro Cardiovascular Center, 
Boston, MA 
Languages Spoken:
English
Accepting New Patients

Christine Seidman is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Seidman is rated as an Elite provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Heart Transplant. Dr. Seidman is board certified in Cardiovascular Disease and Internal Medicine. Dr. Seidman is currently accepting new patients.

What are the latest Familial Hypertrophic Cardiomyopathy Clinical Trials?
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Summary: The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main questions it aims to answer are: Which genes are most commonly affected? What is the frequency of these genetic alterations in our population? Participants will be interviewed in routine medical care visits and their DNA will be ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: June 16, 2026
Published By: National Institutes of Health